How to Write a Press Release That Makes Biotechnology News Clear

A biotechnology announcement can contain years of research and still leave readers unsure what has changed. A useful press release puts the development in context: what the team did, what the evidence shows, and what remains to be tested. Looking at a concise press release example can help with structure, but biotech writers also need to be especially precise about evidence and claims.

Start with the news, not the background

The opening paragraph should state the main development and explain why it matters. Is a company reporting results from a clinical study, beginning a trial, publishing a research finding, or securing funding to advance a platform? Readers should be able to answer that question after a few sentences.

Keep the lead factual. For example, “The research team has reported early safety results from a Phase 1 study of its investigational therapy” is more informative than “A groundbreaking treatment could transform healthcare.” The first sentence identifies the milestone and the stage of development. The second makes a promise that the available data may not support.

Use a headline that reflects the actual result. If a study involved a small group or an early endpoint, say so rather than implying broad clinical benefit. A clear headline may attract fewer inflated expectations, but it gives journalists, investors and the public a sound basis for understanding the announcement.

Give readers enough evidence to judge the claim

Biotechnology news often depends on details that are easy to omit in a short announcement. Include the study type, the number of participants or samples when relevant, the endpoint measured, and the timeframe. Explain whether the results are preliminary, peer-reviewed, published, or presented at a meeting. If a result is based on laboratory or animal research, state that plainly; it is not evidence that a treatment works in people.

Numbers need context. A percentage change can sound substantial without showing the starting value, the comparison group, or the uncertainty around the estimate. Where appropriate, report absolute numbers as well as percentages, and clarify whether a comparison was planned in advance. Avoid presenting a secondary or exploratory result as if it were the study’s primary finding.

Writers should distinguish association from causation and statistical significance from practical importance. If a trial has not yet established efficacy, say so. A press release is not a substitute for a scientific paper, but it should give readers enough information to understand what the evidence can—and cannot—support.

Use quotes to add perspective

A quote should contribute something beyond the facts already stated. A scientist might explain why a particular measurement matters or what question the next stage of research will address. A company leader may describe a development plan, provided the wording does not turn an aspiration into a certainty.

Quotes are also a place to acknowledge limitations. A researcher can make clear that an early result needs confirmation in a larger study. This is not a weakness in the announcement; it helps readers distinguish a promising signal from an established conclusion. Attribute comments accurately, and check that a quoted expert has reviewed the final wording and has no undisclosed conflict relevant to the story.

Make the structure easy to scan

After the lead, arrange details in descending order of importance. A practical sequence is:

• The finding or milestone: What happened, and when?
• The evidence: What study, data or method supports the announcement?
• The context: What is known already, and what is still uncertain?
• The next step: What research, review or development is planned?
• Contacts and company information: Who can answer questions, and what does the organisation do?

Prefer short paragraphs and define technical terms on first use. Keep the main announcement separate from background material, and avoid turning the release into a product brochure. A reporter should be able to find the key result, its limitations and a contact without having to search through promotional language.

Check the digital experience too

Many readers will arrive from a news feed or email on a phone. If the release links to a study summary, company page or data document, those pages should load quickly and work well on small screens. A slow page can make useful supporting information difficult to access, particularly during a busy news cycle.

Teams reviewing their site can use a Core Web Vitals checklist to identify issues with loading speed, layout stability and responsiveness. Osdire is one place organisations can find freelance help across areas such as web development and writing; whichever route a team chooses, technical improvements should make information easier to reach rather than distract from the science.

Review before distribution

Before sending a release, ask a subject-matter expert to check scientific accuracy and a communications or legal reviewer to assess claims, permissions and required disclosures. Confirm that the dates, study stage, affiliations and contact details are correct. Make sure any figures match the underlying source, and do not imply regulatory approval unless it has actually been granted.

Finally, think about what success means. Relevant measures may include accurate media coverage, visits to a research summary, or inquiries from collaborators—not simply the number of times the release was distributed. A well-written announcement cannot guarantee attention, but it can make the science understandable, the claims proportionate and the next questions easier to ask.